Theratechnologies Inc T.TH

Jfm will like this one

[qwerty22]

https://www.businesswire.com/news/home/20201229005036/en/Clovis-Oncology-Submits-Investigational-New-Drug-Applications-for-Novel-Peptide-Targeted-Radionuclide-FAP-2286-for-Therapeutic-and-Imaging-Clinical-Trial

[longterm56]

It seems that other companies think it is important to have a press release upon submission of INDs ... I just don't get it.  It almost speaks of THTX's doubt that they will be accepted. I mean, if they were confident about them they would broadcast it far and wide.    -LT 

[SPCEO1]

While I do not know any of the actual specifics in either protocol, it seems logical to me that TH management are well aware their NASH protocol faces some potential challenges but the cancer one should be relatively strightforward.  Again, we do not know everything that is going on at the company and what advantage it might be in some unrelated thing we could never know about for TH to not

[SABBOBCAT]

They are also now beyond the one year mark on NASDAQ, so they need to file YE financials within 60 days. This means we hopefully should have some sort of update by the end of January. Maybe a competent analyst will grill them on it during the Q&A... I can dream, right? Haha

[qwerty22]

I thought the head-to-head on the THTX and Clovis deals to acquire these products looks interesting. Thtx paid half what Clovis paid upfront, no full clarity on follow on payments but THTX has no royalty aspect. I guess the Clovis product was a little further down the preclinical road as they purchased in late 2019, THTX early 2019, not a lot of difference though really. https://ir

[scarlet1967]

If you go to Clovis website they have a section for partnership so it would be good for THTX to add a similar section to their website once one or more of their programs are in progress. " Building Our Pipeline is Based on Collaboration Clovis is focused on partnering with companies and taking responsibility for developing and commercializing innovative products that may ultimately